1 |
JACOBSON M D , WEIL M , RAFF M C . Programmed cell death in animal development[J]. Cell, 1997, 88 (3): 347- 354.
doi: 10.1016/S0092-8674(00)81873-5
|
2 |
CZABOTAR P E , LESSENE G , STRASSER A , et al. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy[J]. Nat Rev Mol Cell Biol, 2014, 15 (1): 49- 63.
doi: 10.1038/nrm3722
|
3 |
LAVRIK I N . Systems biology of apoptosis signaling networks[J]. Curr Opin Biotechnol, 2010, 21 (4): 551- 555.
doi: 10.1016/j.copbio.2010.07.001
|
4 |
ZOU H , HENZEL W J , LIU X S , et al. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3[J]. Cell, 1997, 90 (3): 405- 413.
doi: 10.1016/S0092-8674(00)80501-2
|
5 |
ELMORE S . Apoptosis: a review of programmed cell death[J]. Toxicol Pathol, 2007, 35 (4): 495- 516.
doi: 10.1080/01926230701320337
|
6 |
LEBER B , LIN J , ANDREWS D W . Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes[J]. Apoptosis, 2007, 12 (5): 897- 911.
doi: 10.1007/s10495-007-0746-4
|
7 |
YOULE R J , STRASSER A . The BCL-2 protein family: opposing activities that mediate cell death[J]. Nat Rev Mol Cell Biol, 2008, 9 (1): 47- 59.
doi: 10.1038/nrm2308
|
8 |
CHIPUK J E , MOLDOVEANU T , LLAMBI F , et al. The BCL-2 family reunion[J]. Mol Cell, 2010, 37 (3): 299- 310.
doi: 10.1016/j.molcel.2010.01.025
|
9 |
PETROS A M , MEDEK A , NETTESHEIM D G , et al. Solution structure of the antiapoptotic protein bcl-2[J]. Proc Natl Acad Sci U S A, 2001, 98 (6): 3012- 3017.
doi: 10.1073/pnas.041619798
|
10 |
LI H , KOLLURI S K , GU J , et al. Cytochrome c release and apoptosis induced by mitochondrial targeting of nuclear orphan receptor TR3[J]. Science, 2000, 289 (5482): 1159- 1164.
doi: 10.1126/science.289.5482.1159
|
11 |
LIN B , KOLLURI S K , LIN F , et al. Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3[J]. Cell, 2004, 116 (4): 527- 540.
doi: 10.1016/S0092-8674(04)00162-X
|
12 |
KOLLURI S K , ZHU X W , ZHOU X , et al. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer[J]. Cancer Cell, 2008, 14 (4): 285- 298.
doi: 10.1016/j.ccr.2008.09.002
|
13 |
BREITSCHOPF K , HAENDELER J , MALCHOW P , et al. Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway[J]. Mol Cell Biol, 2000, 20 (5): 1886- 1896.
doi: 10.1128/MCB.20.5.1886-1896.2000
|
14 |
FURUKAWA Y , IWASE S , KIKUCHI J , et al. Phosphorylation of Bcl-2 protein by CDC2 kinase during G2/M phases and its role in cell cycle regulation[J]. J Biol Chem, 2000, 275 (28): 21661- 21667.
doi: 10.1074/jbc.M906893199
|
15 |
HALDAR S , BASU A , CROCE C M . Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells[J]. Cancer Res, 1998, 58 (8): 1609- 1615.
|
16 |
HARADA H , QUEARRY B , RUIZ-VELA A , et al. Survival factor-induced extracellular signal-regulated kinase phosphorylates BIM, inhibiting its association with BAX and proapoptotic activity[J]. Proc Natl Acad Sci U S A, 2004, 101 (43): 15313- 15317.
doi: 10.1073/pnas.0406837101
|
17 |
YAMAMOTO K , ICHIJO H , KORSMEYER S J . BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M[J]. Mol Cell Biol, 1999, 19 (12): 8469- 8478.
doi: 10.1128/MCB.19.12.8469
|
18 |
DENG X M , RUVOLO P , CARR B , et al. Survival function of ERK1/2 as IL-3-activated, staurosporine-resistant Bcl2 kinases[J]. Proc Natl Acad Sci U S A, 2000, 97 (4): 1578- 1583.
doi: 10.1073/pnas.97.4.1578
|
19 |
DENG X M , GAO F Q , FLAGG T , et al. Mono- and multisite phosphorylation enhances Bcl2's antiapoptotic function and inhibition of cell cycle entry functions[J]. Proc Natl Acad Sci U S A, 2004, 101 (1): 153- 158.
doi: 10.1073/pnas.2533920100
|
20 |
BLAGOSKLONNY M V . Unwinding the loop of Bcl-2 phosphorylation[J]. Leukemia, 2001, 15 (6): 869- 874.
doi: 10.1038/sj.leu.2402134
|
21 |
ADEN J , MUSHTAQ A U , DINGELDEIN A , et al. A novel recombinant expression and purification approach for the full-length anti-apoptotic membrane protein Bcl-2[J]. Protein Expr Purif, 2020, 172105628.
|
22 |
LIAN L Y . NMR studies of weak protein-protein interactions[J]. Prog Nucl Magn Reson Spectrosc, 2013, 71, 59- 72.
doi: 10.1016/j.pnmrs.2012.11.002
|
23 |
范玉丹. Bcl-2蛋白突变体(模拟磷酸化)的纯化和核磁研究[D]. 大连: 大连理工大学, 2017.
|
24 |
YU J B , ZHANG Z , ZHANG Z T , et al. The interaction of alpha-synuclein and intact mitochondria studied by NMR[J]. Chinese J Magn Reson, 2021, 38 (2): 164- 172.
|
|
余锦波, 张偲, 张则婷, 等. Alpha-突触核蛋白与完整线粒体相互作用的NMR研究[J]. 波谱学杂志, 2021, 38 (2): 164- 172.
|
25 |
CHEN X W , HUANG B L , HUANG S H , et al. NMR research on the clpC operon binding region of transcription factor CtsR from Bacillus subtilis[J]. Chinese J Magn Reson, 2021, 38 (2): 155- 163.
|
|
陈晓雯, 黄碧玲, 黄少华, 等. Bacillus subtilis转录因子CtsR蛋白中DNA结合区域的NMR研究[J]. 波谱学杂志, 2021, 38 (2): 155- 163.
|